+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dopamine Antagonist"

From
From
Gastroparesis Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 197 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
Antiemetics and Antinauseants Market Report 2025 - Product Thumbnail Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Antiemetic Drug Market 2024-2028 - Product Thumbnail Image

Antiemetic Drug Market 2024-2028

  • Report
  • August 2024
  • 184 Pages
  • Global
From
Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
D Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

D Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Dopamine Antagonist market within the context of Gastrointestinal Drugs is a subset of the pharmaceutical industry that focuses on the development and production of drugs that target the dopamine receptors in the gastrointestinal tract. These drugs are used to treat a variety of gastrointestinal disorders, including nausea, vomiting, and irritable bowel syndrome. Dopamine antagonists are also used to treat certain types of depression, anxiety, and schizophrenia. The dopamine antagonist market is highly competitive, with many companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and AstraZeneca. Other companies in the market include Sanofi, Takeda, and Daiichi Sankyo. Show Less Read more